To gain more valuable insights, request a sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=362
Growing need to check for infections, birth defects, genetic problems and lung development has led to surge in demand for the amniocentesis needles globally. Prevalence of diabetes among the pregnant women can further lead to excessive buildup of amniotic fluid. According to CDC, 2% to 10% of pregnancies in the U.S. is effected by gestational diabetes every year. Prevalence of diabetes among the pregnant women and increasing level of blood glucose has led to the growing need for removing excessive fluid from around the baby. Instances of miscarriage, vaginal bleeding, and infection to the baby and leaking amniotic fluid has further led to surge in demand for transabdominal sampling of the amniotic fluid.
Increasing demand for conducting biochemical and cytogenetic research studies is further expected to contribute towards growth of the global amniocentesis needle market. Surge in private and government investment in order to upgrade and develop clinics and hospitals has led to increasing number of research and development. Growing investment in research and development for upgrading the clinics and hospitals is expected to contribute towards growth of the global amniocentesis needle market throughout the forecast period.
Report Customization: https://www.factmr.com/connectus/sample?flag=RC&rep_id=362
Growing need to remove excessive amniotic needle has led to surge in demand for amniocentesis needle of 100 - 150 mm length. On the basis of size, the 100 - 150 mm segment is expected to represent the highest revenue growth, accounting for a value of over US$ 30 Mn by the end of 2026. In contrary, the larger than 150 mm size segment is expected to register a significant CAGR throughout the forecast period.
Based on end users, the hospitals segment is expected to witness a significant revenue growth, recording for a value of over US$ 26 Mn by the end of 2017. On the other hand, the other end users segment is expected to register a robust CAGR during the forecast period.
By procedure, the amniocentesis segment is expected to generate significant revenues, accounting for a value of over US$ 20 Mn by the end of 2026. However, the cordocentesis procedure segment is expected to register the highest CAGR throughout the forecast period.
Report Summary: https://www.factmr.com/report/362/amniocentesis-needle-market
We are an insights-driven global market intelligence company with a unique purpose: enabling organizations make better decisions. We do this by creating an ecosystem where an eclectic cognitive collaboration between human imagination and data science leads to path breaking ideas.
Our vision is to foster a pervasive culture where critical business decisions are taken on the basis of facts rather than assumptions and perceptions.
Our mission is empowerment ??" empowerment of free-thought; empowerment of fact-based decisions; empowerment of decisive action.